Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuto Shibata

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Dementia and Geriatric Cognitive Disorders Extra|November 1, 2013
Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese PatientsTomoyuki Nagata, Nobuto Shibata, Shunichiro Shinagawa, et al.
Neuroscience Letters|April 13, 2002
The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's diseaseNobuto Shibata, Tohru Ohnuma, Tadashi Takahashi, et al.
American Journal of Medical Genetics|May 7, 2002
Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese casesNobuto Shibata, Tohru Ohnuma, Tadashi Takahashi, et al.
Neuroscience Letters|November 26, 2009
Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: results from the Juntendo University Schizophrenia Projects (JUSP)Masayuki Higa, Tohru Ohnuma, Hitoshi Maeshima, et al.
Neurobiology of Aging|March 8, 2005
Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's diseaseNobuto Shibata, Tohru Ohnuma, Shinji Higashi, et al.
Hospital Topics|March 29, 2023
Dietary Intake in Older Patients with Dementia Prior to and After the Onset of Coronavirus Disease 2019Taiju Miyagami, Takashi Watari, Shungo Yano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 7, 2008
Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP)Tohru Ohnuma, Yoshie Sakai, Hitoshi Maeshima, et al.
Clinical Interventions in Aging|January 27, 2016
Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot studyTohru Ohnuma, Aiko Toda, Ayako Kimoto, et al.
Dementia and Geriatric Cognitive Disorders Extra|June 7, 2013
Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with DementiaNobuto Shibata, Yumiko Motoi, Hiroyuki Tomiyama, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 9, 2013
Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's diseaseMiwa Komatsu, Nobuto Shibata, Tohru Ohnuma, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Dementia and Geriatric Cognitive Disorders Extra|November 1, 2013
Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese PatientsTomoyuki Nagata, Nobuto Shibata, Shunichiro Shinagawa, et al.
Neuroscience Letters|April 13, 2002
The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's diseaseNobuto Shibata, Tohru Ohnuma, Tadashi Takahashi, et al.
American Journal of Medical Genetics|May 7, 2002
Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese casesNobuto Shibata, Tohru Ohnuma, Tadashi Takahashi, et al.
Neuroscience Letters|November 26, 2009
Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: results from the Juntendo University Schizophrenia Projects (JUSP)Masayuki Higa, Tohru Ohnuma, Hitoshi Maeshima, et al.
Neurobiology of Aging|March 8, 2005
Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's diseaseNobuto Shibata, Tohru Ohnuma, Shinji Higashi, et al.
Hospital Topics|March 29, 2023
Dietary Intake in Older Patients with Dementia Prior to and After the Onset of Coronavirus Disease 2019Taiju Miyagami, Takashi Watari, Shungo Yano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 7, 2008
Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP)Tohru Ohnuma, Yoshie Sakai, Hitoshi Maeshima, et al.
Clinical Interventions in Aging|January 27, 2016
Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot studyTohru Ohnuma, Aiko Toda, Ayako Kimoto, et al.
Dementia and Geriatric Cognitive Disorders Extra|June 7, 2013
Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with DementiaNobuto Shibata, Yumiko Motoi, Hiroyuki Tomiyama, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 9, 2013
Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's diseaseMiwa Komatsu, Nobuto Shibata, Tohru Ohnuma, et al.
Pageof 9